Lincolnshire veterinary surgeon David Bull MRCVS has won a Vet Futures ‘Headlines of tomorrow’ competition with his entry: ‘Vets and medics collaborate to prevent human and animal obesity’. 

The competition was held at BSAVA Congress in April where Vet Futures-themed fortune cookies contained a message asking those attending ‘What future headline do you want to see?’ and providing a weblink to enter the competition.  

David, a joint partner at Vets4Pets in Lincoln South and an Advanced Practitioner in General Small Animal Surgery, said: "The headline was inspired by topical issues, having ‘One Health’ in mind and the issue of obesity in our patients, as well as the general human population. I feel that these are some of the big issues of our time, especially that of obesity which has been linked to so many other diseases and is essentially a self-induced problem.

“We see so many overweight cats, dogs and rabbits on a daily basis. It seems to be becoming a more common problem, as well as seemingly more accepted in society. This is to the extent that we have some clients that come in worried because they have been told that their dog is too thin, when in actual fact they are in an ideal body condition and are being compared to overweight pets which have become perceived as normal.”

Some of the other topics raised in the competition include the veterinary profession taking the lead in tackling ‘superbugs’, veterinary surgeons topping job satisfaction and wellbeing polls and the profession taking a leading role in One Health and medical advancements.

Clark Dental has launched the new Nomad Handheld X-Ray machine from Aribex™.

According to the company, Nomad already has a superb track record as a practical, effective and recognised state-of-the-art device. It boasts a multitude of benefits and features and is suitable for many different environments. Two rechargeable batteries provide 150 exposures each, and it’s compatible with both digital sensors and traditional X-ray film.

The operator is protected by a patented internal radiation shield as well as an external backscatter shield, which the company says provides excellent protection: one operator would have to expose over 10,000 E-speed films per year in order to approach the lowest measurable dose on a monitoring badge. With a direct digital sensor, the scatter dose is even less.

For further information, please contact the exclusive UK supplier, Clark Dental, on Tel: 01270 613750 or email maria@clarkdental.co.uk

The Royal College of Veterinary Surgeons Council and the Veterinary Nursing Council have decided that there will be no increase in registration and retention fees for veterinary surgeons and veterinary nurses for 2012.

Last year, the Councils decided that a lower than inflation increase should apply to fees for 2011 to help mitigate the impact of the difficult economic climate on veterinary surgeons and veterinary nurses. Members who are over 70 and who cease practising do not have to pay fees if they wish to remain on the Register.

Bradley Viner, RCVS Treasurer said: "We know times are tough financially for many people and hope that freezing fees will help a little. Professional regulation can be costly, but we try to keep fees as low as possible." 

The RCVS financial policy remains that fee increases should be small and incremental in order to avoid a need for periodic sharp fee hikes resulting from inflationary pressures. 

Fees for 2012 will be as follows: 

Virbac has launched Cooldent, described as a highly palatable, fast-acting tablet to freshen dogs' breath.

Claire Lewis, Product Manager, explained: "Bad breath in dogs is unpleasant and is most frequently caused by a build-up of plaque and calculus on their teeth. 

"Cooldent's natural ingredients have an anti-plaque action and help both to maintain a balanced intestinal flora and to reduce gas production. They also help to freshen dogs’ mouths by contributing to the reduction of volatile compounds, produced by bacteria which can cause halitosis."

She added: "We are delighted to add Cooldent to our comprehensive dental range, alongside our VeggieDent, natural, all-vegetable, highly palatable teeth-cleaning chews for dogs and Vet Aquadent, an easy-to-use drinking water additive which helps to fight dental plaque and tartar formation in dogs and cats."

The RCVS Mind Matters Initiative is to host its fifth biennial mental health research symposium to highlight current contributions to veterinary mental health research from around the globe on Friday 10th October from 9am to 5pm at The Eastside Rooms in Birmingham, UK.

The theme for the symposium this year is ‘Advancing veterinary mental health research: learning from the past, considering the present, and looking to the future’.

The day will consist of a variety of oral presentations and poster presentations, and there will be a number of exhibitors, including charitable organisations and wider animal health and welfare organisations.

The College is inviting all those interested in the field of veterinary mental health to attend the day.

RCVS Council member and Chair of the Mind Matters Initiative, Dr Louise Allum, said: “Our symposium presents a fantastic opportunity for knowledge exchange in the veterinary mental health sphere so that, together, we can continue to foster a compassionate environment and build a solid evidence-base for veterinary mental health research to grow and evolve.

“This is an inclusive event open to all with an interest in veterinary mental health including vets, nurses, students, practice managers, academics, healthcare professionals, policy makers, mental health advocates and everyone in between.”

MMI Lead Rapinder Newton added: “We have come a long way in developing our understanding of mental health in veterinary professionals over the past ten years but still have a way to go.

“Only through continued collaboration with mental health researchers, and learning from other allied professions, can we efficiently work towards our shared goal of enhancing mental health and support within the veterinary professions.

“This is why events such as our symposium are so important.

"Veterinary mental health is a small but growing field. Creating environments for open discussion and networking are key to advancing our understanding of where the challenges lie.

"By extension, this also plays an invaluable role in learning how research can be applied in a practical manner to help improve the lives of veterinary professionals which, ultimately, aids in upholding animal health and welfare too.”

https://www.eventbrite.co.uk/e/mind-matters-initiative-research-symposium-2025-tickets-1247144485729 

Hill’s Pet Nutrition has launched Prescription Diet Feline c/d Multicare, formulated to manage both struvite and oxalate urinary stones. It's appropriate for cats with feline idiopathic cystitis, which accounts for an estimated 64% of all FLUTD cases. The new diet replaces x/d, which will be discontinued.

According to Hill's, a significant benefit is that c/d contains no excess salt and therefore presents no risk to cats that have hidden kidney disease. Libby Sheridan, Veterinary Affairs Manager, said: “It’s something that is always at the back of our minds when cats have shown signs of urinary tract problems: has there been damage to the kidneys that I can’t yet detect? We need to be cautious when it comes to managing urinary disease in cats. Limiting salt with careful diet formulation and therefore avoiding potentially worsening compromised kidneys is important in long term management.”

Feline c/d Multicare contains controlled levels of magnesium, calcium, phosphorus and oxalate to reduce the constituents of crystals and calculi, added citrate to reduce stone formation and enhanced levels of B6 specifically to decrease the risk of oxalate formation. Increases in omega-3 fatty acids help ensure that the inflammatory response is ameliorated, which is particularly important in the management of feline idiopathic cystitis. 

Hills continue to recommend s/d for dissolution of struvite calculi and k/d in cases of feline urate calculi. Feline urinary disease is, of course, a condition that requires long term intervention to guard against recurrence and c/d Multicare is available in a variety of flavours and formats, including tender chunks in gravy pouches, 156 g tins and dry in chicken and ocean fish varieties, ensuring there is a enough choice to satisfy the most discerning of cats.

For more information call Hill’s Customer Service on 0800 282 438 or (ROI) 1-800 626002.

MSD Animal Health is urging vets to reassess their approach to managing neonatal calf diarrhoea, following new evidence showing a rise in resistance to paromomycin.

The March 2025 Cattle Highlights Report from the Royal GD in the Netherlands has revealed that the proportion of paromomycin-resistant isolates has jumped from 48% in 2021 to 72% in 2024.

The report also highlights an increase in the detection of cryptosporidiosis in calves up to 14 days of age.

MSD says that while it is unclear whether paromomycin is being used to treat E.coli or cryptosporidiosis, the rising use of the antibiotic could be contributing to greater exposure and increased resistance in E.coli K99.

Kat Baxter-Smith MRCVS (pictured), a vet advisor at MSD Animal Health, said: “What we need now is a mindset shift—moving away from routine antibiotic use and towards a more robust, preventative management strategy.

“It’s not about eliminating treatment altogether but using it only when it is really needed.”

“Vaccination, clean pens, and ensuring that every calf receives the right volume and quality of colostrum are the real cornerstones of effective scour control.

“Using vaccines such as Bovilis Rotavec Corona for rotavirus, coronavirus, and E.coli and Bovilis Cryptium for Cryptosporidium parvum is one of the most effective ways to reduce the incidence of neonatal diarrhoea.

"By vaccinating the dam, we ensure the calf has the best possible immunity at birth by ingesting the fortified colostrum and transition milk in the first days of life, which significantly reduces reliance on antibiotics and minimises disease risks.”

The report emphasises best-practice principles such as effective colostrum management, good hygiene and housing, balanced dry cow transition and strategic vaccination of the dam.

The report also recommends halofuginone (Halocur) as the first-line treatment for cryptosporidiosis, due to its targeted action and significantly lower risk of contributing to AMR.

Kat added: "By embracing these proactive strategies, vets and farmers can take a crucial step towards safeguarding calf health, reducing reliance on antibiotics, and combating the growing threat of antimicrobial resistance.”

https://issuu.com/gezondheidsdienstvoordieren/docs/highlights_report_cattle-march_2025 

Two equine journals have joined forces to create a free online collection of their recent articles on endocrinology to raise awareness of these common disorders and to provide veterinary surgeons with what they say is a definitive source of references all in one place.

The collection of references published by Equine Veterinary Education (EVE) and Equine Veterinary Journal (EVJ) covers a range of topics within the field of endocrinology and includes authoritative review articles on insulin dysregulation², glucocorticoids and laminitis³ and paraneoplastic syndromes⁴.

The initiative has been made possible with the support of British Equine Veterinary Association Trust and has been compiled by leading international authorities on equine endocrinology, Professor Philip Johnson, of University of Missouri and Professor Nicholas Frank of Tufts University, Boston and the University of Nottingham.

They say that equine endocrine disorders, such as Pituitary pars intermedia dysfunction (PPID), are becoming more promptly identified and treated, thanks to ongoing research and advances in diagnosis, pharmacokinetics and management protocols.

PPID, or Cushing's, is a progressive neurodegenerative condition that is more easily recognised in its advanced form in older horses. Surveys show a PPID prevalence rate of up to 22% in horses over the age of 15⁵, with the odds of developing clinical signs associated with PPID increasing by approximately 20% per year after this age.

Insulin dysregulation (ID), characterised by increased insulin response to oral sugars, hyperinsulinaemia and insulin resistance, is identified in both PPID and equine metabolic syndrome (EMS)². Both PPID and EMS have been linked to the development of recurrent laminitis with subsequent high risk of mortality⁶. The exact mechanisms which link insulin to laminitis remain to be clarified¹ but this online collection highlights several studies, which partially address this important jigsaw^7-12.

Best practice for the management of EMS is outlined by Professors Nick Frank and Ray Geor in the December issue of EVE¹³. The first goal is to induce weight loss, and guidelines for designing diets for obese equids are provided. Exercise and dietary management¹⁴ have been shown to reduce the clinical signs and indices of inflammation in equine metabolic syndrome^{13 - 15}, however, further studies are needed to quantify the efficacy of these management changes on long-term outcomes.

The online collection also includes several studies addressing the diagnosis of PPID. The value of plasma adrenocorticotropin hormone (ACTH), when interpreted with seasonally adjusted reference ranges, is discussed by several authors^18-20. Professors Frank and Geor advocate it as the most readily accessible test for monitoring PPID cases in a field setting, although they maintain that the thyrotropin- releasing hormone (TRH) stimulation test is more sensitive and therefore has advantages when diagnosing PPID in its early stages¹³.

Pergolide has emerged as the drug of first choice for treatment of PPID¹³. While many vets recommend the early introduction of medication in the hope that it may avert the specter of laminitis, at present, there are no trials comparing pergolide with alternatives. Furthermore, there have been no long-term studies to show that horses treated with pergolide before the onset of clinical signs of PPID have better outcomes, including a reduced incidence of developing laminitis, than horses in which treatment is delayed until clinical signs become apparent.

Professor Celia Marr, Editor of Equine Veterinary Journal said: "Better control of PPID and insulin dysregulation should lower the risk of laminitis to help improve the health and longevity of many predisposed horses and ponies.

"Raising awareness of the benefits of early diagnosis and sharing the latest research on these and other associated conditions are imperative to provide horse owners with the best diagnostic and treatment programmes for their horses. However, it is easy to under-estimate obesity: horse owners need to think about improving management of their horses' feeding and exercise in order to avert problems before they become a veterinary issue."

References

1. Kritchevsky, S.E. and Johnson, P.J.  (2014) Current Status and Future Directions: Equine pituitary pars intermedia dysfunction and Equine Metabolic Syndrome. Equine Veterinary Journal 46, to add.
2. Frank, N. and Tadros, E.M. (2014) Insulin Dysregulation. Equine Veterinary Journal 46, to add.
3. Cornelisse, C.J. and Robinson, N.E. (2013) Glucocortioid therapy and the risk of equine laminitis. Equine Veterinary Education 25, 39-46.
4. Axiak, S. and Johnson, P.J. (2012) Paraneoplastic manifestations of cancer in horses. Equine Veterinary Education 24, 367-376.
5. McGowan, T.W., Pinchbeck, G.P. and McGowan, C.M. (2013) Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses. Equine Veterinary Journal 45, 74-79.
6. Tadros, E.M. and Frank, N. (2011) Endocrine disorders and laminitis. Equine Veterinary Education 25, 152-162.
7. TÓth, F., Frank, N., Martin-JimÉNez, T., Elliott, S.B., Geor, R.J. and Boston, R.C. (2010) Measurement of C-peptide concentrations and responses to somatostatin, glucose infusion, and insulin resistance in horses. Equine Veterinary Journal 42, 149- 155.
8. Venugopal, C.S., Eades, S., Holmes, E.P. and Beadle, R.E. (2011) Insulin resistance in equine digital vessel rings: An in vitro model to study vascular dysfunction in equine laminitis. Equine Veterinary Journal 43, 744-749.
9. Borer-Weir, K.E., Menzies-Gow, N.J., Bailey, S.R., Harris, P.A. and Elliott, J. (2013) Seasonal and annual influence on insulin and cortisol results from overnight dexamethasone suppression tests in normal ponies and ponies predisposed to laminitis. Equine Veterinary Journal 45, 688-693.
10. Burns, T.A., Watts, M.R., Weber, P.S., McCutcheon, L.J., Geor, R.J. and Belknap, J.K. (2013) Distribution of insulin receptor and insulin-like growth factor-1 receptor in the digital laminae of mixed-breed ponies: An immunohistochemical study. Equine Veterinary Journal 45, 326-332.
11. Gauff, F., Patan-Zugaj, B. and Licka, T.F. (2013) Hyperinsulinaemia increases vascular resistance and endothelin-1 expression in the equine digit. Equine Veterinary Journal 45, 613-618.
12. Dunkel, B., Wilford, S.A., Parkinson, N.J., Ward, C., Smith, P., Grahame, L., Brazil, T. and Schott II, H.C. (2014) Severe hypertriglyceridaemia in horses and ponies with endocrine disorders. Equine Veterinary Journal 46, to add.
13. Frank, N. and Geor, R. (2014) Current best practice in clinical management of equine endocrine patients. Equine Veterinary Education to add.
14. Hudson, A.B., McGowan, C.M. and Morgan, R. (2012) The clinical management of EMS at the Philip Leverhulme equine hospital. Equine Veterinary Journal 44, 6.
15. Menzies-Gow, N.J., Wray, H., Bailey, S.R., Harris, P.A. and Elliott, J. (2014) The effect of exercise on plasma concentrations of inflammatory markers in normal and previously laminitic ponies. Equine Veterinary Journal 46.
16. Rendle, D.I., Rutledge, F., Hughes, K.J., Heller, J. and Durham, A.E. (2013) Effects of metformin hydrochloride on blood glucose and insulin responses to oral dextrose in horses. Equine Veterinary Journal 45, 751-754.
17. Owers, R. and Chubbock, S. (2013) Fight the fat! Equine Veterinary Journal 45, 5-5.
18. Copas, V.E.N. and Durham, A.E. (2012) Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction. Equine Veterinary Journal 44, 440-443.
19. McGowan, T.W., Pinchbeck, G.P. and Mc Gowan, C.M. (2013) Evaluation of basal plasma α-melanocyte-stimulating hormone and adrenocorticotrophic hormone concentrations for the diagnosis of pituitary pars intermedia dysfunction from a population of aged horses. Equine Veterinary Journal 45, 66-73.
20. Rendle, D.I., Litchfield, E., Heller, J. and Hughes, K.J. (2014) Investigation of rhythms of secretion and repeatability of plasma adrenocorticotropic hormone concentrations in healthy horses and horses with pituitary pars intermedia dysfunction. Equine Veterinary Journal 46, to add.

The British Veterinary Association has published some research showing that 21% of vets now use AI technology in their daily work, and is inviting veterinary professionals to a discussion on the subject at this year's BVA Live (Birmingham NEC, 2pm, 12th June 2025)

Apparently the commonly reported use of AI technology was for radiography diagnostics and reporting (44%), followed by laboratory diagnostics and reporting (27%), communications with clients (11%) or to assist with administrative work (7%).

Vets were asked about the benefits and risks of using AI technology in their work.

The most common reported benefit was data interpretation (55%), followed by diagnostic testing (49%), saving time more generally (40%) and for routine admin tasks or note taking (38%).

The most commonly reported risks of AI were the possibility that results are interpreted without context (83%) or that AI is used incorrectly, without follow up checks (82%).

The other reported risks were an overreliance on AI undermining human skills (68%) and a lack of data protection (25%).

BVA Junior Vice President Rob Williams said: “It’s fascinating to see how many vet teams are already using AI technology in their daily work.

"The massive boom in the use of these tools represents an exciting opportunity for the profession, particularly around diagnostics and interpreting large data sets.

"But as well as benefits there are clear challenges and risks, so this timely session is a great opportunity to address some of the ethical questions around the use of technology when it comes to treating animals and ensuring their welfare.

"It’s set to be an interesting debate, with the chance for delegates to pose questions to our incredibly knowledgeable panel, and I hope many of you will join us to add your voice to the discussion.”

On the AI discussion panel at BVA Live will be: Nick Jackson, Director, Veterinary Surgeon, Council Member - NGJ Locum Ltd, Ben O'Halloran, Policy Officer - BVA and Nicolò Frisiani, Co-founder and CEO - Lupa Pets.

https://bvalive.vetshow.com/conference-programme 

Photo: www.depositphotos.com

Krka has launched 'Ears to Tail', a range of veterinary practice resources designed to encourage a responsible, risk-based approach to the use of parasiticides.

The materials include pet owner guides, reception posters and slides to display on waiting room TV.

They complement the Krka veterinary professional guide on responsible risk-based parasiticide use for cats and dogs that was developed in conjunction with Ian Wright BVMS MSc MRCVS and launched last year.

Renzo Di Florio, Krka’s Technical Veterinary Adviser said:  “In first opinion veterinary practice, where the majority of consultations last 15 minutes or less, time is short and in-depth discussions are not always possible.

"The guides provide comprehensive information on common parasites, practical advice on prevention and treatment and information on risk assessment.

"And by aligning with ESCCAP guidelines, the guides help address the delicate balance between animal health, human health and environmental protection – a true One Health issue.”

https://www.krka.co.uk/veterinary-knowledge-hub/articles/risk-based-parasiticide-use-for-cats-and-dogs

Pete Wedderburn MRCVS is reporting on the latest veterinary developments in the USA, with a daily blog from the Western Veterinary Conference in Las Vegas.

You can read / subscribe to Pete's engaging blog here.

Early bird registration deadline is 3 March for the SAMSoc pre-BSAVA meet. Please register soon!

Visit www.samsoc.org for details.

Entries for our case report competition are invited before Friday 1 March 2019.

The Bella Moss Foundation and the Royal Society of Medicine have announced 'One Health', a conference which will bring together experts from the veterinary and medical sectors to collaborate on infectious disease.

Subjects under discussion will include infection control, antimicrobial resistance and the threats posed by emerging zoonotic diseases. Amongst the speakers will be Professor Peter Borriello, Chief Executive of the Veterinary Medicines Directorate and Professor Anthony Kessel, Director of Public Health England. The audience will include policy makers and clinicians together with researchers and academics from both human and veterinary medicine.

Jill Moss, President of the Bella Moss Foundation, said: "With antimicrobial resistance and updated protocols hitting the headlines regularly, our speakers will discuss the key issues. For instance, what exactly is the current status of antimicrobial resistance? How is it affecting our lives? What are the veterinary, medical and research professions doing to resolve the challenges we face - and how can they persuade policy makers to take a united stand on the issue?"

Tom Keith - Welsh president of comparative medicine network, Royal Society of Medicine, said: "Antimicrobial resistance is a global issue requiring education, information and action. The conference programme will provide anyone with an interest in antimicrobial resistance a current and rounded perspective on this important and pressing issue."

For more information, visit: www.onehealthbmf.com.